This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Gareth Carpenter
20 May 2020

Thermo Fisher seals US government deal to supply VTM tubes for COVID-19 testing

CDMO aims to ramp up production to 8 million tubes per week via $40 million Lenexa site expansion

Thermo Fisher Scientific has secured a US government contract to supply viral transport media (VTM) tubes for collection and transport to laboratories of patient samples to test for COVID-19, the contract development and manufacturing organisation said on Monday.

Thermo Fisher said that due to strong demand for COVID-19 testing, it will expand capacity at its Lenexa site in Kansas with a new USD 40 million facility dedicated to VTM production helping it to scale production to more than 8 million VTM-filled tubes per week.

The new Lenexa facility is scheduled to be completed in Q3 and will create around 300 full-time jobs.

Thermo Fisher’s VTM production has already increased from 50,000 to more than one million VTM-filled tubes per week in response to the coronavirus pandemic.

Describing the production ramp-up as impressive, Thermo Fisher chairman, president and chief executive officer Marc Casper said employees deserved recognition for their ingenuity and dedication.

“We have a proven blueprint for high-quality VTM production in Lenexa and look forward to bringing significant new capacity online as quickly as possible to continue the necessary testing ramp-up in the US,” he added.

As of yet, no financial details of the US government contract have been released.

To ensure accuracy of COVID-19 test results, VTM must be manufactured and dispensed into tubes in an aseptic environment.

Last week, Thermo Fisher announced a collaboration with WuXi Diagnostics and Mayo Clinic to develop a COVID-19 antibody test, ELISA, to determine if a patient has been exposed to SARS-CoV-2. The company is in the process of seeking US FDA Emergency Use Authorization and international regulatory authorizations for the test.

Mentioned Companies
Thermo Fisher Scientific Inc.
View company profile
Gareth Carpenter

Related News